FDA Approves 2nd Car-T Therapy – for Adult Lymphoma

On October 18th, the U.S. Food and Drug Administration approved another cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other kinds of treatment....